Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
Sanofi
Philippe Moreau; Meletios-Athanasios Dimopoulos; Joseph Mikhael; Kwee Yong; Marcelo Capra; Thierry Facon; Roman Hajek; Ivan Špička; Ross Baker; Kihyun Kim; Gracia Martinez; Chang-Ki Min; Ludek Pour; Xavier Leleu; Albert Oriol; Youngil Koh; Kenshi Suzuki; Marie-Laure Risse; Gaelle Asset; Sandrine Macé; Thomas Martin; IKEMA study group